The reduction of FGFR activation by MPI knockdown also resulted in decreased downstream signaling through FRS2 and either AKT or MAPK in the U-251 and SKMG-3 glioma cell lines, respectively. The gene discussed is AKT1; the disease is central nervous system cancer.